- Home
- WOW vs GOSS Comparison
WOW vs GOSS Comparison
Compare WOW & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- GOSS
- Stock Information
- Founded
- WOW 2001
- GOSS 2015
- Country
- WOW United States
- GOSS United States
- Employees
- WOW N/A
- GOSS N/A
- Industry
- WOW Cable & Other Pay Television Services
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- GOSS Health Care
- Exchange
- WOW Nasdaq
- GOSS Nasdaq
- Market Cap
- WOW 285.5M
- GOSS 347.8M
- IPO Year
- WOW 2017
- GOSS 2019
- Fundamental
- Price
- WOW $5.09
- GOSS $2.47
- Analyst Decision
- WOW Hold
- GOSS Strong Buy
- Analyst Count
- WOW 2
- GOSS 4
- Target Price
- WOW $5.20
- GOSS $8.50
- AVG Volume (30 Days)
- WOW 3.4M
- GOSS 3.1M
- Earning Date
- WOW 08-11-2025
- GOSS 08-05-2025
- Dividend Yield
- WOW N/A
- GOSS N/A
- EPS Growth
- WOW N/A
- GOSS N/A
- EPS
- WOW N/A
- GOSS N/A
- Revenue
- WOW $604,800,000.00
- GOSS $40,237,000.00
- Revenue This Year
- WOW N/A
- GOSS N/A
- Revenue Next Year
- WOW N/A
- GOSS $30.65
- P/E Ratio
- WOW N/A
- GOSS N/A
- Revenue Growth
- WOW N/A
- GOSS N/A
- 52 Week Low
- WOW $3.06
- GOSS $0.66
- 52 Week High
- WOW $5.79
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- WOW 77.52
- GOSS 68.08
- Support Level
- WOW $5.06
- GOSS $2.38
- Resistance Level
- WOW $5.12
- GOSS $2.65
- Average True Range (ATR)
- WOW 0.03
- GOSS 0.15
- MACD
- WOW 0.03
- GOSS 0.03
- Stochastic Oscillator
- WOW 70.00
- GOSS 76.67
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.